Coronavirus

Ivermectin sales in June surpass entire 2019 figures

In June, the Brazilian pharmaceutical industry registered around 8.6 million sales of the medication Ivermectin, more than the total number of the drug sold in 2019 (8.2 million), according to data provided by the Industrial Pharmaceutical Union (Sindusfarma). The spike in sales in June represents a 1,222 percent increase in comparison to the same period in 2019, which recorded only 650,000 sales.

The medicine is normally used for the treatment of parasites, but is now associated with the treatment for Covid-19 in Brazil — despite the lack of evidence of its effectiveness in treating the coronavirus.

In June, the Brazilian pharmaceutical industry registered around 8.6 million sales of the medication Ivermectin, more than the total number of the drug sold in 2019 (8.2 million), according to data provided by the Industrial Pharmaceutical Union (Sindusfarma). The spike in sales in June represents a 1,222 percent increase in comparison to the same period in 2019, which recorded only 650,000 sales.

The medicine is normally used for the treatment of parasites, but is now associated with the treatment for Covid-19 in Brazil — despite the lack of evidence of its effectiveness in treating the coronavirus.

The drug has been widely distributed by city and state-wide administrations since the beginning of April, causing confusion among Brazilians as to whether they should use Ivermectin, even without clear evidence that it helps patients recover from Covid-19.Recently, The Brazilian Report covered the wave of Covid-19 “cure” drugs in Latin America spearheaded by another suspect drug, hydroxychloroquine, which has been widely touted by President Jair Bolsonaro

The drug has been widely distributed by city and state-wide administrations since the beginning of April, causing confusion among Brazilians as to whether they should use Ivermectin, even without clear evidence that it helps patients recover from Covid-19.

Recently, The Brazilian Report covered the wave of Covid-19 “cure” drugs in Latin America spearheaded by another suspect drug, hydroxychloroquine, which has been widely touted by President Jair Bolsonaro.

Support this coverage →
Rafael Lima

Rafael is a Communication student at Wake Forest University, and a student fellow of the Pulitzer Center on Crisis Reporting.

Recent Posts

Madonna concert to inject BRL 300 million into Rio economy

The city of Rio de Janeiro estimates that a Madonna concert this Saturday on Copacabana…

10 hours ago

Panama ready to vote as Supreme Court clears frontrunner

Latin America’s trend of banning opposition candidates from elections has caught on in an ever-growing…

11 hours ago

Sabesp privatization edges closer with São Paulo legislation

The São Paulo City Council on Thursday approved legislation authorizing Brazil’s largest city to sign…

14 hours ago

Brazil’s AI regulation gets first draft to guide upcoming debates

The preliminary report on AI regulations presented to Brazil’s Senate last week provides a middle-of-the-road…

15 hours ago

Ayrton Senna, a true Brazilian hero

In 2000, Formula 1 great Michael Schumacher had just racked up his 41st race win,…

1 day ago

OECD improves Brazil’s GDP growth forecast once again

Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…

1 day ago